Single Strand Break | List of Frontiers open access articles

Review

Published on 27 Apr 2022

Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications

in Molecular Innate Immunity

Carlos Wagner S. Wanderley
Tatiana Strava Correa
Mariana Scaranti
Fernando Queiroz Cunha
Romualdo Barroso-Sousa

Frontiers in Immunology

doi 10.3389/fimmu.2022.816642

7,455 views
33 citations

Original Research

Published on 30 Oct 2020

Activity of Human Apurinic/Apyrimidinic Endonuclease APE1 Toward Damaged DNA and Native RNA With Non-canonical Structures

in Cell Death and Survival

Anastasia T. Davletgildeeva
Alexandra A. Kuznetsova
Olga S. Fedorova
Nikita A. Kuznetsov

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2020.590848

6,404 views
21 citations

Review

Published on 04 Dec 2023

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization

in Radiation Oncology

Yi Zhang
Lijie Liang
Zheng Li
Ying Huang
Ming Jiang
Bingwen Zou
Yong Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1295579

3,102 views

Review

Published on 05 Dec 2012

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma

in Radiation Oncology

Koji Yoshimoto
Masahiro Mizoguchi
Nobuhiro Hata
Hideaki Murata
Ryusuke Hatae
Toshiyuki Amano
Akira Nakamizo
Tomio Sasaki

Frontiers in Oncology

doi 10.3389/fonc.2012.00186

17,913 views
112 citations

Original Research

Published on 08 Jan 2021

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

in Thoracic Oncology

Benjamin B. Morris
Nolan A. Wages
Patrick A. Grant
P. Todd Stukenberg
Ryan D. Gentzler
Richard D. Hall
Wallace L. Akerley
Thomas K. Varghese
Susanne M. Arnold
Terence M. Williams

Frontiers in Oncology

doi 10.3389/fonc.2020.585551

9,103 views
16 citations

Original Research

Published on 03 Jun 2022

Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress

in Molecular and Cellular Oncology

Tao Han
Jing Tong
Mengxin Wang
Yu Gan
Bo Gao
Jiaxiang Chen
Youxun Liu
Qian Hao
Xiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.821366

6,729 views
15 citations

Original Research

Published on 02 Nov 2021

APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells

in Molecular and Cellular Pathology

Md Akram Hossain
Yunfeng Lin
Garrett Driscoll
Jia Li
Anne McMahon
Joshua Matos
Haichao Zhao
Daisuke Tsuchimoto
Yusaku Nakabeppu
Jianjun Zhao

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.738502

9,249 views
19 citations

Articles

Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications

Activity of Human Apurinic/Apyrimidinic Endonuclease APE1 Toward Damaged DNA and Native RNA With Non-canonical Structures

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma

MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma

Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress

APE2 Is a General Regulator of the ATR-Chk1 DNA Damage Response Pathway to Maintain Genome Integrity in Pancreatic Cancer Cells